Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « selective »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
selection < selective < selectively  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000260 (2012) Michele Petenzi ; Michele Verga ; Michele Largy ; Michele Hamon ; Michele Doria ; Michele Teulade-Fichou ; Aurore Guédin [France] ; Aurore Mergny [France] ; Aurore Mella ; Aurore FrecceroCationic Pentaheteroaryls as Selective G‐Quadruplex Ligands by Solvent‐Free Microwave‐Assisted Synthesis
000351 (2011) Talia Harris ; Talia Giraudeau [France] ; Talia FrydmanKinetics from Indirectly Detected Hyperpolarized NMR Spectroscopy by Using Spatially Selective Coherence Transfers
000761 (2008) Jurriaan Beckers [Pays-Bas] ; Frédèric Clerc [France] ; Jan Hendrik Blank ; Gadi Rothenberg [Pays-Bas]Selective Hydrogen Oxidation Catalysts via Genetic Algorithms
000942 (2007) Jan Endrik Blank ; Jurriaan Beckers ; Paul Collignon ; Frédéric Clerc [France] ; Gadi Rothenberg [Pays-Bas]A “Green Route” to Propene through Selective Hydrogen Oxidation
000B61 (2004) J. H. Thébault [Belgique] ; J. H. Guillaume [France] ; J. H. Levy [Israël]Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Rasagiline: A Potent, Selective, and Irreversible Monoamine Oxidase Type B Inhibitor
000F17 (2001) Malika El Yacoubi [France] ; Catherine Ledent [Belgique] ; Marc Parmentier [Belgique] ; Ennio Ongini [Italie] ; Jean Costentin [France] ; Jean-Marie Vaugeois [France]In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261
000F77 (2001) Philippe Allain [France] ; Frédérique Etcharry-Bouyx [France] ; Didier Le Gall [France]A Case Study of Selective Impairment of the Central Executive Component of Working Memory after a Focal Frontal Lobe Damage
001281 (1999) H. Hall [Suède] ; C. Halldin [Suède] ; D. Guilloteau [France] ; S. Chalon [France] ; P. Emond [France] ; J.-C. Besnard [France] ; L. Farde [Suède] ; G. Sedvall [Suède]Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I
001371 (1999) H. Becq [France] ; O. Bosler [France] ; M. Geffard [France] ; A. Enjalbert [France] ; J. P. Herman [France]Anatomical and functional reconstruction of the nigrostriatal system in vitro: Selective innervation of the striatum by dopaminergic neurons
001461 (1998) Geneviève Baziard-Mouysset [France] ; Salouma Younes [France] ; Youssef Labssita [France] ; Marc Payard [France] ; Daniel-Henri Caignard [France] ; Marie-Claire Rettori [France] ; Pierre Renard [France] ; Bruno Pfeiffer [France] ; Béatrice Guardiola-Lemaitre [France]Synthesis and structure-activity relationships of novel 2-amino alkyl chromones and related derivatives as a site-selective ligands
001909 (1995) S. Bernard [France] ; C. Paillat [France] ; T. Oddos [France] ; M. Seman [France] ; R. Milcent [France]Selective and potent monoamine oxidase type B inhibitors: substituted semicarbazones and acylhydrazones of aromatic aldehydes and ketones
001C82 (1992) Robert Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease
001F35 (1989) E. C. Hirsch [France] ; A. M. Graybiel [États-Unis] ; Yves Agid [France]Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
001F41 (1989) Monique Zreika [France] ; J. R. Fozard [France, Suisse] ; M. W. Dudley [États-Unis] ; Ph. Bey [États-Unis] ; I. A. Mcdonald [États-Unis] ; M. G. Palfreyman [États-Unis]MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease
002313 (1982) J. M. Studler [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; J. C. Legrand [France] ; Yves Agid [France]CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "selective" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "selective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    selective
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024